The Joint Juice False Advertising Settlement totals approximately $90 million, making it the largest settlement ever in a dietary supplement false advertising case. Premier Nutrition Corporation, the maker of Joint Juice glucosamine supplements, agreed to the settlement after plaintiffs alleged the company deceived consumers by claiming its products could relieve joint pain and improve joint health when scientific evidence did not support those claims. Premier Nutrition denies all allegations of wrongdoing and maintains its advertising was truthful, but chose to settle to avoid the cost and uncertainty of continued litigation.
If you purchased Joint Juice glucosamine supplements in California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Pennsylvania, or New York during the eligible time periods, you may be entitled to a cash payment. Multi-state class members could receive approximately $10 or $25 per eligible unit purchased, while New York purchasers could receive roughly $50 per unit. The claim deadline is May 15, 2026 for multi-state claims and May 18, 2026 for New York claims.
Table of Contents
- What Are The False Advertising Allegations Against Joint Juice And What Does Premier Nutrition Deny?
- How The Courts Ruled On Joint Juice’s Marketing Claims
- Breaking Down The $90 Million Settlement Fund
- How To File A Claim Before The May 2026 Deadline
- What This Settlement Means For Supplement Industry Advertising
- The Role Of Independent Versus Industry-Funded Research
- What Happens Next And Broader Implications For Consumers
- Frequently Asked Questions
What Are The False Advertising Allegations Against Joint Juice And What Does Premier Nutrition Deny?
The case originated in 2013 as a putative nationwide consumer class action filed in the Northern District of California under the case name *Mullins v. Premier Nutrition Corp.* (Case No. 13-cv-01271-RS). A parallel class action was led by representative Mary Beth Montera in New York. At the heart of both lawsuits was a straightforward claim: that the packaging on joint Juice products made promises about joint pain relief and joint health improvement that were not backed by legitimate science. Plaintiffs introduced peer-reviewed, non-industry-funded studies to support their position. According to the lawsuit, 10 meta-analyses examining the clinical effects of glucosamine and chondroitin found that “glucosamine, alone or in combination with chondroitin, does not work” for joint function or pain relief.
That is a significant body of independent research, and it formed the backbone of the plaintiffs’ argument that Joint Juice’s marketing was misleading consumers who were spending money on a product that could not deliver what the label suggested. Premier Nutrition pushes back on this narrative entirely. The company denies all allegations of wrongdoing and insists that its Joint Juice products provide the joint health benefits advertised on the packaging. Premier Nutrition points to industry-funded studies that it says support its claims. This is a common tension in supplement litigation: plaintiffs cite independent research, while defendants rely on studies funded by industry stakeholders. The settlement itself is not an admission of liability by either side. Both parties agreed to resolve the dispute to avoid the risk and expense of appeals and further litigation.
How The Courts Ruled On Joint Juice’s Marketing Claims
The legal battle did not end with just allegations. A jury actually weighed the evidence and found that the statements on Joint Juice’s packaging were deceptive under New York law. That is not a minor procedural ruling. A group of ordinary people reviewed the marketing claims, considered the scientific evidence, and concluded that consumers were misled. The district court then awarded $50 in statutory damages per sale to the New York class, which totaled approximately $8.3 million, plus nearly $4.6 million in prejudgment interest. However, the story did not end there. On August 6, 2024, the Ninth Circuit weighed in with an opinion authored by Judge Morgan Christen (Nos.
22-16375, 22-16622). The appellate court affirmed the core finding that Premier Nutrition materially misled New York consumers, which was a significant win for the plaintiffs. But the Ninth Circuit vacated and remanded the damages calculation, holding that aggregate statutory damages should be assessed for proportionality and reasonableness rather than under the *State Farm* due process standard typically used for punitive damages. This distinction matters for consumers following other supplement lawsuits. If you are watching a similar false advertising case, be aware that even when a jury sides with consumers, the damages phase can become its own lengthy battle. The Ninth Circuit’s ruling here sets a precedent for how courts should evaluate aggregate statutory damages in consumer class actions, which could influence how future supplement cases are resolved. The remand likely contributed to both sides reaching the $90 million settlement rather than continuing to litigate the damages question.
Breaking Down The $90 Million Settlement Fund
The combined settlement totals approximately $90 million, split into two distinct funds. The Multi-State Settlement Fund contains $70,839,813.53 and covers consumers who purchased Joint Juice in California (from March 1, 2009), Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, and Pennsylvania, with each state having its own specific start date for eligible purchases. All multi-state purchases must have been made through December 31, 2022 to qualify. The New York Settlement Fund amounts to $19,160,186.47, which includes the $8,312,450 court judgment that was already awarded, court-approved attorneys’ fees and expenses, a class representative service award, and post-judgment interest. New York class members’ eligible purchases span from December 5, 2013 through December 28, 2021.
The different time windows reflect the separate procedural histories of the multi-state and New York cases. What does this mean in practical terms for individual claimants? Multi-state class members can expect approximately $10 or $25 per eligible Joint Juice unit purchased, depending on the specific product. New York purchasers stand to receive roughly $50 per unit, reflecting the higher statutory damages that the jury originally awarded. If you were a regular Joint Juice buyer during the eligible period, multiple purchases could add up to a meaningful payout. Someone who purchased a unit every month over several years, for example, could potentially receive a few hundred dollars or more depending on their state and product type.
How To File A Claim Before The May 2026 Deadline
Filing a claim requires visiting the official settlement website at www.JointJuiceSettlement.com. The site has separate sections for multi-state claims and New York claims, so make sure you select the correct one based on where you made your purchases. If you bought Joint Juice in multiple eligible states, you will want to review both sections to understand how your claims should be submitted. You can also call 1-888-921-0720 for assistance. The claim form deadline is May 15, 2026 for the multi-state settlement and May 18, 2026 for New York claims.
A fairness hearing is scheduled for May 5, 2026 at 10:00 a.m., where the court will consider final approval of the settlement. The court granted preliminary approval on January 8, 2026. If you plan to object to or opt out of the settlement, you should review the deadlines and procedures on the settlement website carefully, as those deadlines may differ from the claim filing deadline. One tradeoff worth considering: filing a claim means you accept the settlement terms and release your individual claims against Premier Nutrition related to Joint Juice. If you believe your personal damages significantly exceed the per-unit payout amounts, you may want to consult with an attorney about whether opting out and pursuing an individual claim makes more sense. For most consumers, however, the settlement payout will likely exceed what they could recover individually given the cost of private litigation versus the price of a glucosamine supplement.
What This Settlement Means For Supplement Industry Advertising
This case highlights a persistent problem in the dietary supplement industry: the gap between what labels promise and what independent science supports. The supplement market in the United States is regulated differently from pharmaceuticals. Products can make certain health claims without undergoing the rigorous clinical trial process required for prescription drugs. This regulatory environment creates fertile ground for advertising disputes, and the Joint Juice case is one of the most significant examples to date. One limitation consumers should be aware of is that this settlement does not establish a blanket rule that glucosamine supplements are ineffective. The legal findings are specific to Premier Nutrition’s advertising claims about Joint Juice products.
Other glucosamine manufacturers may make different claims with different supporting evidence, and those would need to be evaluated independently. The settlement also does not prevent Premier Nutrition from selling Joint Juice going forward, though the company may need to adjust its marketing language. The $90 million price tag sends a clear warning to supplement companies across the industry. When a jury finds your advertising deceptive and a federal appeals court affirms that finding, the financial consequences can be severe. Companies that rely heavily on industry-funded studies to support marketing claims while independent research points in the opposite direction should take note. Consumers, meanwhile, should remain skeptical of health claims on supplement packaging and look for products backed by independent, peer-reviewed research rather than industry-sponsored studies alone.
The Role Of Independent Versus Industry-Funded Research
The Joint Juice case puts a spotlight on a critical issue in supplement litigation and consumer decision-making. Plaintiffs relied on 10 meta-analyses of peer-reviewed, non-industry-funded studies, all of which concluded that glucosamine does not work for joint function or pain relief. Premier Nutrition countered with industry-funded studies that the company says support its claims.
This is not unique to Joint Juice. Across the supplement and pharmaceutical industries, studies funded by the companies that manufacture the products being tested have historically shown more favorable results than independently funded research. When evaluating any health product, consumers benefit from checking who paid for the studies cited in support of the product’s claims.
What Happens Next And Broader Implications For Consumers
The fairness hearing on May 5, 2026 will determine whether the court grants final approval to the settlement. Assuming approval, distribution of payments to claimants who filed on time will follow, though the exact timeline will depend on any remaining administrative steps. If you purchased Joint Juice in an eligible state during the covered period, the most important thing you can do right now is file your claim before the deadline.
Looking ahead, this case is likely to be cited in future supplement false advertising lawsuits as both a legal precedent and a benchmark for settlement size. The Ninth Circuit’s ruling on how aggregate statutory damages should be assessed for proportionality will influence how courts handle similar consumer class actions. For consumers, the broader takeaway is that class action litigation remains one of the most effective tools for holding supplement companies accountable when their advertising outpaces the science.
Frequently Asked Questions
Who is eligible for the Joint Juice settlement?
Consumers who purchased Joint Juice glucosamine supplements in California (from March 1, 2009), Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, or Pennsylvania through December 31, 2022 are eligible for the multi-state settlement. New York purchasers who bought the product between December 5, 2013 and December 28, 2021 are covered under the separate New York settlement.
How much money can I receive from the Joint Juice settlement?
Multi-state class members may receive approximately $10 or $25 per eligible Joint Juice unit purchased, depending on the specific product. New York class members may receive approximately $50 per unit. The total payout depends on how many units you purchased during the eligible period.
What is the deadline to file a Joint Juice settlement claim?
The claim form deadline is May 15, 2026 for multi-state claims and May 18, 2026 for New York claims. Claims can be filed at www.JointJuiceSettlement.com or by calling 1-888-921-0720.
Do I need a receipt to file a claim?
The settlement website at www.JointJuiceSettlement.com has details on documentation requirements. Visit the site or call 1-888-921-0720 to learn what proof of purchase, if any, is required for your specific claim.
Does Premier Nutrition admit that Joint Juice does not work?
No. Premier Nutrition denies all allegations of wrongdoing and maintains that its Joint Juice products provide the advertised joint health benefits. The settlement is not an admission of liability. However, a jury did find the product’s packaging statements deceptive under New York law, and the Ninth Circuit affirmed that Premier Nutrition materially misled New York consumers.
Can I still buy Joint Juice products?
The settlement does not prohibit the sale of Joint Juice products. The case focused on the advertising claims made on the packaging, not on banning the product itself.
You Might Also Like
- Mid America Pet Food Salmonella Recall Settlement: What The Allegations Say And What The Company Denies
- Joint Juice False Advertising Settlement: Who Gets Credit Monitoring And For How Long
- Joint Juice False Advertising Settlement: What Happens If You Miss The Deadline